Tweenvest Stocks

Arterra Bioscience S.p.A. (BIT: ARBS)

Health Care · Biotechnology · IT

€3.10

+4.73% today · 0.0% 1Y

Arterra Bioscience S.p.A. (BIT: ARBS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $22.06M and employs 36 people.

Over the last twelve months the share price has gained 0.0%, trading between 2.60 and 3.58.

Tweenvest scores Arterra Bioscience S.p.A. across four factors: quality 83/100, value 44/100, growth 83/100. Its strongest factor is quality.

ARBS price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$22.06M
Revenue (TTM)
$5.94M
P/E
—
EPS
—
Dividend yield
—
Beta (5Y)
0.64
52-week high
€3.58
52-week low
€2.60
Avg volume (3M)
—
Shares outstanding
6.66M
Employees
36
Next earnings
—

About Arterra Bioscience S.p.A.

Arterra Bioscience S.p.A. is a biotechnology company fundamentally driven by scientific research, concentrating on the discovery and development of a wide range of ingredients and nature-based solutions. The firm's activities encompass the creation of advanced technological frameworks, innovative extraction methodologies, and foundational raw materials, specifically tailored for the beauty, agricultural, and nutritional supplement sectors. Established in 2003, Arterra Bioscience S.p.A. is headquartered in Naples, Italy.

ISIN
IT0005386369
Founded
2003
Listed since
Oct 28, 2019
Exchange
Borsa Italiana
Currency
EUR
CompanyMarket capPriceDay
genOway Société anonymeENXTPA: ALGEN$22.83M€2.22+0.91%
Grace Breeding LtdTASE: GRAC$22.77M₪16.52+2.80%
BCAL Diagnostics LimitedASX: BDX$22.29MAU$0.09+7.41%
GenSight Biologics S.A.ENXTPA: SIGHT$22.09M€0.08-4.06%
Helyx Industries S.p.A.BIT: HLX$21.81M€0.77+3.49%
Resverlogix Corp.TSX: RVX$21.74MCA$0.09-5.56%
TScan Therapeutics, Inc.NasdaqGM: TCRX$21.72M$0.23-28.80%
Modalis Therapeutics CorporationTSE: 4883$21.60M¥32.00-3.03%

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.